Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2019
Reporting Period: Third fiscal quarter ended September 30, 2019, and the nine months ended September 30, 2019.
This filing serves to announce the Company's financial results for the specified periods via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus prior comparable periods. It only indicates that results for the third quarter and nine months of 2019 were announced.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the full press release referenced in Item 2.02.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain specific revenue, net income, and cash flow figures for Q3 and the nine months ended September 30, 2019.
- Verify year-over-year and quarter-over-quarter growth rates for key performance indicators.
- Check for any updated financial guidance or outlook provided in the press release.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial results.